Thermo Fisher (TMO) Director Scott Sperling Receives 62.96 Stock Units

What Happened

• Scott M. Sperling, a Director of Thermo Fisher Scientific (TMO), was granted 62.96 deferred stock units on 2026-09-26. The filing lists the units at $675.00 per unit, for a total grant value of $42,498 (62.96 × $675). The transaction is reported as an award/acquisition (derivative instrument convertible into common stock).

Key Details

• Transaction date: 2026-09-26; Form 4 filed: 2026-09-29.
• Award: 62.96 deferred stock units at $675.00 per unit; total value ≈ $42,498.
• Instrument: Derivative stock units convertible into common stock on a 1-for-1 basis (Footnote F1).
• Plan details: Units credited under the Issuer’s Deferred Compensation Plan for Directors; they represent deferred directors’ retainers and are distributable as stock upon cessation of director service or a change of control (Footnote F2).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Filing date provided; no late-filing flag noted in the supplied data.

Context

• These are deferred stock units (not an open-market purchase or sale). They represent a right to receive common stock later (convertible 1-for-1) and are part of routine director compensation deferral—common and not an explicit buy/sell market signal.
• For retail investors, awards like this mainly indicate routine compensation alignment with shareholders rather than active insider buying.